methyl-jasmonate and Leukemia--Lymphoid

methyl-jasmonate has been researched along with Leukemia--Lymphoid* in 1 studies

Other Studies

1 other study(ies) available for methyl-jasmonate and Leukemia--Lymphoid

Article	Year
The anticancer agent methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells. Leukemia, 2003, Volume: 17, Issue:11 Topics: Acetates; Base Sequence; Binding Sites; Cycloheximide; Cyclopentanes; Dactinomycin; Humans; JNK Mitogen-Activated Protein Kinases; Kinetics; Leukemia, Lymphoid; Mitogen-Activated Protein Kinases; Oligodeoxyribonucleotides; Oxylipins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Growth Regulators; Protein Synthesis Inhibitors; Transcription Factor AP-1; Tumor Cells, Cultured	2003

Article

Year

The anticancer agent methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells.

Leukemia, 2003, Volume: 17, Issue:11

Topics: Acetates; Base Sequence; Binding Sites; Cycloheximide; Cyclopentanes; Dactinomycin; Humans; JNK Mitogen-Activated Protein Kinases; Kinetics; Leukemia, Lymphoid; Mitogen-Activated Protein Kinases; Oligodeoxyribonucleotides; Oxylipins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Growth Regulators; Protein Synthesis Inhibitors; Transcription Factor AP-1; Tumor Cells, Cultured

2003